Characterization of the ß-Adreno Receptor Kinase 1 (ßARK1) as a Novel Therapeutic Target in Heart Failure using Conditional and Tissue-Specific Knockout Mice

Antragsteller Dr. Philip Raake

Fachliche Zuordnung Kardiologie, Angiologie

Förderung Förderung von 2006 bis 2008

Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 28996692

Erstellungsjahr 2008

Zusammenfassung der Projektergebnisse

Keine Zusammenfassung vorhanden

Cardlo-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther. 2008 Jan; 15(1): 12-7
Raake PW, Hinkel R, Müller S, Delker S, Kreuzpointner R, Kupatt C, Katus HA, Klelnschmidt JA, Boekstegers P, Müller OJ
G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ Res. 2008 Aug 15;103(4):413-22
Raake PW, Vinge LE, Gao E, Boucher M, Rengo G, Chen X, DeGeorge BR Jr, Matkovich S, Houser SR, Most P, Eckhart AD, Dorn GW 2nd, Koch WJ
Gene therapy in heart failure. Circ Res. 2008 Jun 20; 102(12): 1458-70
Vinge LE, Raake PW, Koch WJ
Uncovering G protein-coupled receptor klnase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc Natl Acad Sci U S A. 2008 Aug 26; 105(34): 12457-62
Martini JS, Raake PW, Vinge LE, DeGeorge B Jr, Chuprun JK, Harris DM, Gao E, Eckhart AD, Pitcher JA, Koch WJ